COLORADO STATE UNIVERSITY
Currently, enrolled in the Cell and Molecular Biology PhD program at CSU in Dawn Duval’s lab studying cancer biology in canines.
IMMUNITYBIO INC.
Performed experiments to generate new viral vectors into cells/yeast to create different types of viruses. After which, expanded the virus to make viral seed stocks (VSS) to be used in large scale manufacturing (GMP). Simultaneously, I characterized the different viruses by transducing cells/yeast to perform multiplicity of infection (MOI) studies, then performed titer on the samples via either qPCR or protein detection. Along with these tasks, I was instrumental in qualifying and transferring the analytical methods for the company’s new mRNA platform to the QC department by creating SOPs for guidance.
REVVITY
Researched and developed, or improved upon, innovative new technologies for CRISPR Cas9 systems. Lost position due to slow sales resulting from COVID-19 shutdowns.
VIRIDIAN THERAPEUTICS, INC.
Research and development of an oncology drug that is currently in phase 2 clinical trials. While the drug was initially in the clinic, I assisted in creating data for patent purposes and helped present findings in several scientific journals, of which are referenced below. I also aided in the development of other drugs to treat fibrosis and heart disease. As a member of the Translational Biology group, I was tasked with examining our drug against, or in conjunction with, the standard of care. I performed these experiments, most of which involving small molecule compounds, and used statistical analysis to examine drug synergism and dose effectiveness.
UNIVERSITY OF COLORADO HEALTH AND SCIENCE CENTER
Created a transgenic mouse with a Cre-Lox insert which is activated by administration of tamoxifen to examine the effects of Multiple Sclerosis at different stages of development. Carried out clinical trials and managed patient records for a Multiple Sclerosis clinic.